Point72 Asset Management’s MediciNova MNOV Stock Holding History

Point72 Asset Management’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,675	Closed	-$16.6K	–	2542
2023 Q1	$16.6K	Buy	+7,675	New	+$17.6K	﹤0.01%	1992

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Point72 Asset Management's MNOV Position: Q2 2023 in Review

Point72 Asset Management sold out of MediciNova (MNOV) in Q2 2023, closing a stake of 7,675 shares — an estimated $16.6K sold.

Point72 Asset Management first reported a position in MNOV in Q1 2023 and held it in 1 quarter. The position peaked at $16.6K in Q1 2023. 34 funds tracked by Wall St. Rank hold MNOV as of Q2 2023.

Point72 Asset Management reported no remaining MediciNova position as of Q2 2023 after selling out during the quarter.
Point72 Asset Management sold 7,675 MediciNova shares in Q2 2023, an estimated $16.6K.
Point72 Asset Management first reported a position in MediciNova in Q1 2023 and held it in 1 quarter.
Point72 Asset Management's MediciNova position peaked at $16.6K in Q1 2023.
34 funds tracked by Wall St. Rank held MediciNova as of Q2 2023.

Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.